Named on one round in the feed.
Since 2026-11-04
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Emvena Therapeutics, Inc. A biotechnology company developing placenta-targeted mRNA medicines for serious maternal and fetal disorders | Seed Developing, 4 sources | n/a | 2026-11-04 | [ PART ] |
No one else named on these rounds.